Tender detail

Non-exclusive rebate agreement for morphine for 2027–2028

Summary

DAK-Gesundheit intends to conclude non-exclusive medicine rebate agreements with interested pharmaceutical companies for medicines containing morphine in the specified dosage forms (FTA, HKP and SMT; ATC N02AA01). The agreements are scheduled to run from 1 January 2027 to 31 December 2028, with an option to extend once for 12 months. They will end automatically if an exclusive agreement for the active substance takes effect sooner.

Reference number
99f89f5c-0585-42b2-bb78-e482415b55bc
Buyer
Country
Germany (DEU)
Procedure
Open procedure
CPV
33600000 Pharmaceutical products
Deadline
2029-11-05
Status
Open
Contract subject
Supplies
Estimated value
1,00 EUR
Source
DEU_BKMS

More tender information after sign-in

The public view shows key tender details. Sign in to open official links, documents and AI tender support.